TAM diagnosis requires the presence of GATA1 mutations together with increased blasts and/or clinical features suggestive of TAM in a neonate with constitutional trisomy 21 [5,6,10]. This evidence concerns the gene GATA1 and transient myeloproliferative syndrome.